ToxStrategies Welcomes Nathaniel Collins, D.V.M., Ph.D., DACVP
ToxStrategies is pleased to announce that Dr. Nate Collins has joined our firm as a Senior Consultant. Dr. Collins has 25 years’ experience… read more
Latest News
ToxStrategies is Pleased to Announce 2024 Staff Promotions
ToxStrategies LLC, EpidStrategies, a Division of ToxStrategies LLC, and Modality Solutions are pleased to announce 2024 promotions for nearly three-dozen of our scientists, epidemiologists, statisticians,… read more
ToxStrategies is at World Orphan Drug Congress in Boston!
ToxStrategies is excited to be attending, exhibiting, and hosting a round table at the World Orphan Drug Congress (WODC), April 23–25, 2024. This… read more
Food and Supplements Industries Eye New NDIN Guidance from FDA
The Food and Drug Administration has released a Final Guidance for Industry to address some ongoing issues with procedures and timing for submitting… read more
ToxStrategies is Presenting and Exhibiting at SOT 2024!
ToxStrategies is excited to be attending, presenting, and exhibiting at the Society of Toxicology’s 63rd Annual Meeting and ToxExpo, March 9th 2024, to… read more
Healthcare resource use by PSVT patients undergoing cardiac ablation
HEORStrategies’ Dr. Naomi Sacks is a co-author on a study of healthcare resource use and costs in cardiac arrhythmia patients with paroxysmal supraventricular… read more
EPA issues a framework for identifying eye irritation or corrosion hazards for new chemicals reviewed under TSCA, prioritizing non-animal methods
On January 8, 2024, EPA issued a new framework for identifying eye irritation or corrosion hazards for new chemicals reviewed under the Toxic… read more
ToxStrategies has exciting news from the FDA Center for Veterinary Medicine!
The Center for Veterinary Medicine (CVM) is paving the way for innovation in the animal feed industry! In a recent Letter to Industry,… read more